Video

Dr. Alter on Kidney Cancer Drugs From 2005-2010

Author(s):

Robert S. Alter, MD

Robert S. Alter, MD, Co-chief, Urologic Oncology, John Theurer Cancer Center, on kidney cancer drugs from the year 2005 to 2010.

Robert S. Alter, MD, Co-chief, Urologic Oncology, John Theurer Cancer Center, on kidney cancer drugs from the year 2005 to 2010.

Related Videos
Minoo Battiwalla, MD, MS
Cynthia X. Ma, MD, PhD
Jyoti Patel, MD
Leo I. Gordon, MD
Bertram Yuh, MD, MISM, MSHCPM
Alexander Drilon, MD
David Rimm, MD, PhD
Laahn Ho Foster, MD
David C. Fisher, MD
Michel Ducreux, MD, PhD, head, Gastrointestinal Oncology Unit, head, Gastrointestinal Oncology Tumor Board, Gustave Roussy; professor, oncology, Paris-Saclay University
Related Content
Yair Lotan, MD, professor, urology, chief, Urologic Oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Medical Center
October 24th 2024

Investigative Targeted Agents Are Set to Expand the BCG-Unresponsive NMIBC Treatment Paradigm

Oncology Unplugged
August 7th 2024

Park and Grivas Expand on Treatment Updates in Bladder Cancer

Alan Tan, MD
October 18th 2024

Long-Term IO-IO Data Contest the Role of Frontline TKIs in Advanced RCC

Oncology Unplugged
July 24th 2024

Park and Sonpavde on Sacituzumab Govitecan Plus Enfortumab Vedotin in Metastatic Urothelial Cancer

Neal Shore, MD, FACS, United States chief medical officer of Surgery and Oncology at GenesisCare
October 17th 2024

Bel-Sar Elicits Complete Responses in NMIBC

Jacqueline Brown, MD, of Winship Cancer Institute
October 15th 2024

ADCs Usher in a Complex New Era of Disease and Toxicity Management in Bladder Cancer